The incidence of diabetes mellitus is rising, with the total number of people affected worldwide projected to increase to 366 million by 2030.
1 The most common cause of vision impairment in patients with diabetic retinopathy is macular edema.
2 Macular edema is believed to result from a loss of the normal blood-retinal barrier with an increase in vascular permeability. It may also include impaired removal of proteins and fluid, with subsequent accumulation of fluid and cystoid formation.
3,4 Vascular endothelial growth factor contributes to this process, and therapies targeting vascular endothelial growth factor have proved effective in improving visual acuity.
5